Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by BOEHRINGER INGELHEIM

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
010460 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
011752 New Drug Application Approval New formulation (S) Standard review drug
012836 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
015874 New Drug Application Approval New formulation (P) Priority review drug
016402 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
017407 New Drug Application Approval New formulation (P) Priority review drug
017503 New Drug Application Approval New molecular entity (NME); New combination (P) Priority review drug
017571 New Drug Application Approval New formulation (S) Standard review drug
017659 New Drug Application Approval New formulation (P) Priority review drug
018761 New Drug Application Approval New formulation (S) Standard review drug
018873 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
018891 New Drug Application Approval New formulation (S) Standard review drug
019085 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019817 New Drug Application Approval New formulation (P) Priority review drug
020228 New Drug Application Approval New formulation (P) Priority review drug
020291 New Drug Application Approval New combination (S) Standard review drug
020393 New Drug Application Approval New formulation (S) Standard review drug
020394 New Drug Application Approval New formulation (S) Standard review drug
020520 New Drug Application Approval New formulation (S) Standard review drug
020579 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020636 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020667 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020745 New Drug Application Approval New formulation (S) Standard review drug
020850 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020884 New Drug Application Approval New combination (P) Priority review drug
020933 New Drug Application Approval New formulation
020938 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021162 New Drug Application Approval New combination (S) Standard review drug
021395 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021527 New Drug Application Approval New formulation (S) Standard review drug
021530 New Drug Application Approval New formulation (S) Standard review drug
021698 New Drug Application Approval New formulation (S) Standard review drug
021747 New Drug Application Approval New formulation (S) Standard review drug
021814 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021822 New Drug Application Approval New formulation (P) Priority review drug
021936 New Drug Application Approval New formulation (S) Standard review drug
022292 New Drug Application Approval New formulation (P) Priority review drug
022401 New Drug Application Approval New combination (S) Standard review drug
022421 New Drug Application Approval New formulation (S) Standard review drug
022512 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
022514 New Drug Application Approval New formulation (S) Standard review drug
074662 Abbreviated New Drug Application Approval
103769 Biologic License Application Approval
201152 New Drug Application Approval New formulation (S) Standard review drug
201280 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
201281 New Drug Application Approval New combination (S) Standard review drug
201292 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
203108 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
204629 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
205832 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
206073 New Drug Application Approval New combination (S) Standard review drug
206111 New Drug Application Approval New combination (S) Standard review drug
206756 New Drug Application Approval New combination (S) Standard review drug
207070 New Drug Application Approval 9 (S) Standard review drug
208026 New Drug Application Approval New combination (S) Standard review drug
761025 Biologic License Application Approval

Back to Companies who have applied for FDA Drug Approval